Study Data
| Project uploaded by: | Amrita |
| Project ID: | IMP_100034 |
| Title: | Understanding Metabolic Alterations in Advanced Stage Chronic Kidney Disease Patients by NMR-based metabolomics |
| Project Description: | Understanding metabolic alterations in CKD is crucial, as serum creatinine-based diagnosis lacks precision, affecting key clinical decisions. In this study, a 1 H NMR-based metabolomics approach was employed to distinguish between advanced-stage CKD (ASCKD) patients and healthy controls (HC), as well as within the ASCKD stages (Stage 4 and Stage 5). Serum samples from 52 ASCKD (S4, S5) and 25 HC were analyzed. Multivariate and univariate analysis revealed distinct metabolic patterns across groups, providing insights into CKD pathophysiology and associated pathway alterations. Compared to HC, six metabolites were significantly altered in both stage 4 and 5 CKD patients with upregulated creatinine, urea, myoinositol, choline, N, N-dimethylglycine, and downregulated tyrosine, showing potential as biomarkers with AUC above 0.8 in ROC analysis. Additionally, myo-inositol, dimethylamine, N, N-dimethylglycine, and choline correlate positively with creatinine while tyrosine correlates negatively. Amino acid metabolism was downregulated in S5 indicating more severity. Within ASCKD patients, significant alterations were observed in metabolites such as glutamate, glutamine, alanine, threonine, myo-inositol, dimethylamine, citrulline, urea, citrate, and betaine. Pathway analysis identified five distinct metabolic pathways associated with CKD progression. Consequently, we propose a panel of serum metabolites which should be monitored along with creatinine for following CKD progression. Markers of oxidative stress, inflammation, and gut dysbiosis were evident in the perturbed metabolic profile due to the systemic impact of CKD. |
| Research Area: | Biological Sciences |
| Funding Source: | NA |
| Project Contributors: | Amrita Sahu 1,2 , Upasna Gupta 1,2 , Bikash Baishya 1,2 *, Dharmendra Singh Bhadauria 3 *, Neeraj Sinha 1, 2 |
| Sr.No | Sample ID | Sample Name | Organism | Source | Sample Preparation Protocol | Sample Type | Experimental Condition | Time of treatment | Variant/Variety | Gender | Age | Replicates | Storage Conditions | Extraction Protocol | Number of files per sample |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IMSM_101442 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 2 | IMSM_101443 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 3 | IMSM_101444 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 4 | IMSM_101445 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 5 | IMSM_101446 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 6 | IMSM_101447 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 7 | IMSM_101448 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 8 | IMSM_101449 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 9 | IMSM_101450 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 10 | IMSM_101451 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 11 | IMSM_101452 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 12 | IMSM_101453 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 13 | IMSM_101454 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 14 | IMSM_101455 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 15 | IMSM_101456 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 16 | IMSM_101457 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 17 | IMSM_101458 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 18 | IMSM_101459 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 19 | IMSM_101460 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 20 | IMSM_101461 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 21 | IMSM_101462 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 22 | IMSM_101463 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 23 | IMSM_101464 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 24 | IMSM_101465 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 25 | IMSM_101466 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 26 | IMSM_101467 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 27 | IMSM_101468 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 28 | IMSM_101469 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 29 | IMSM_101470 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 30 | IMSM_101471 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 31 | IMSM_101472 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 32 | IMSM_101473 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 33 | IMSM_101474 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 34 | IMSM_101475 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 35 | IMSM_101476 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 36 | IMSM_101477 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 37 | IMSM_101478 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 38 | IMSM_101479 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 39 | IMSM_101480 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 40 | IMSM_101481 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 41 | IMSM_101482 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 42 | IMSM_101483 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 43 | IMSM_101484 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 44 | IMSM_101485 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 45 | IMSM_101486 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 46 | IMSM_101487 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 47 | IMSM_101488 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 48 | IMSM_101489 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 49 | IMSM_101490 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 50 | IMSM_101491 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 51 | IMSM_101492 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 52 | IMSM_101493 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 53 | IMSM_101494 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 54 | IMSM_101495 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 55 | IMSM_101496 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 56 | IMSM_101497 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 57 | IMSM_101498 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 58 | IMSM_101499 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 59 | IMSM_101500 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 60 | IMSM_101501 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 61 | IMSM_101502 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 62 | IMSM_101503 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 63 | IMSM_101504 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 64 | IMSM_101505 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 65 | IMSM_101506 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 66 | IMSM_101507 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 67 | IMSM_101508 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 68 | IMSM_101509 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 69 | IMSM_101510 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 70 | IMSM_101511 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 71 | IMSM_101512 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 72 | IMSM_101513 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 73 | IMSM_101514 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 74 | IMSM_101515 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 75 | IMSM_101516 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 76 | IMSM_101517 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
|
| 77 | IMSM_101518 | Human Blood | Homo sapiens | Serum | Serum samples were prepared for ^1H NMR analysis following the protocol outlined by Nagana Gowda, G. A., & Raftery, D. (2023). | Serum | Untreated | NA | NA | NA | NA | NA | 80C |
Metabolite extraction from serum samples was performed in accordance with the procedure described by Nagana Gowda, G. A., & Raftery, D. (2022),optimized for ^1H NMR-based metabolomics analysis. |
| Sr.No | NMR Exp ID | Sample Name/ID | Reference Standard | NMR Instrument Name | NMR Instrument Type | NMR Experiment Type | NMR Spectrometer Frequency | NMR Probe | NMR Probe temperature | NMR Solvent | NMR tube size | Data Transformation (Software/s Used) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | IME_100687 | Human Blood / IMSM_101442 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 2 | IME_100688 | Human Blood / IMSM_101443 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 3 | IME_100689 | Human Blood / IMSM_101444 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 4 | IME_100690 | Human Blood / IMSM_101445 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 5 | IME_100691 | Human Blood / IMSM_101446 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 6 | IME_100692 | Human Blood / IMSM_101447 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 7 | IME_100693 | Human Blood / IMSM_101448 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 8 | IME_100694 | Human Blood / IMSM_101449 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 9 | IME_100695 | Human Blood / IMSM_101450 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 10 | IME_100696 | Human Blood / IMSM_101451 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 11 | IME_100697 | Human Blood / IMSM_101452 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 12 | IME_100698 | Human Blood / IMSM_101453 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 13 | IME_100699 | Human Blood / IMSM_101454 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 14 | IME_100700 | Human Blood / IMSM_101455 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 15 | IME_100701 | Human Blood / IMSM_101456 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 16 | IME_100702 | Human Blood / IMSM_101457 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 17 | IME_100703 | Human Blood / IMSM_101458 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 18 | IME_100704 | Human Blood / IMSM_101459 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 19 | IME_100705 | Human Blood / IMSM_101460 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 20 | IME_100706 | Human Blood / IMSM_101461 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 21 | IME_100707 | Human Blood / IMSM_101462 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 22 | IME_100708 | Human Blood / IMSM_101463 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 23 | IME_100709 | Human Blood / IMSM_101464 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 24 | IME_100710 | Human Blood / IMSM_101465 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 25 | IME_100711 | Human Blood / IMSM_101466 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 26 | IME_100712 | Human Blood / IMSM_101467 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 27 | IME_100713 | Human Blood / IMSM_101468 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 28 | IME_100714 | Human Blood / IMSM_101469 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 29 | IME_100715 | Human Blood / IMSM_101470 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 30 | IME_100716 | Human Blood / IMSM_101471 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 31 | IME_100717 | Human Blood / IMSM_101472 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 32 | IME_100718 | Human Blood / IMSM_101473 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 33 | IME_100719 | Human Blood / IMSM_101474 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 34 | IME_100720 | Human Blood / IMSM_101475 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 35 | IME_100721 | Human Blood / IMSM_101476 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 36 | IME_100722 | Human Blood / IMSM_101477 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 37 | IME_100723 | Human Blood / IMSM_101478 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 38 | IME_100724 | Human Blood / IMSM_101479 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 39 | IME_100725 | Human Blood / IMSM_101480 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 40 | IME_100726 | Human Blood / IMSM_101481 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 41 | IME_100727 | Human Blood / IMSM_101482 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 42 | IME_100728 | Human Blood / IMSM_101483 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 43 | IME_100729 | Human Blood / IMSM_101484 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 44 | IME_100730 | Human Blood / IMSM_101485 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 45 | IME_100731 | Human Blood / IMSM_101486 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 46 | IME_100732 | Human Blood / IMSM_101487 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 47 | IME_100733 | Human Blood / IMSM_101488 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 48 | IME_100734 | Human Blood / IMSM_101489 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 49 | IME_100735 | Human Blood / IMSM_101490 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 50 | IME_100736 | Human Blood / IMSM_101491 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 51 | IME_100737 | Human Blood / IMSM_101492 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 52 | IME_100738 | Human Blood / IMSM_101493 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 53 | IME_100739 | Human Blood / IMSM_101494 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 54 | IME_100740 | Human Blood / IMSM_101495 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 55 | IME_100741 | Human Blood / IMSM_101496 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 56 | IME_100742 | Human Blood / IMSM_101497 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 57 | IME_100743 | Human Blood / IMSM_101498 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 58 | IME_100744 | Human Blood / IMSM_101499 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 59 | IME_100745 | Human Blood / IMSM_101500 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 60 | IME_100746 | Human Blood / IMSM_101501 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 61 | IME_100747 | Human Blood / IMSM_101502 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 62 | IME_100748 | Human Blood / IMSM_101503 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 63 | IME_100749 | Human Blood / IMSM_101504 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 64 | IME_100750 | Human Blood / IMSM_101505 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 65 | IME_100751 | Human Blood / IMSM_101506 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 66 | IME_100752 | Human Blood / IMSM_101507 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 67 | IME_100753 | Human Blood / IMSM_101508 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 68 | IME_100754 | Human Blood / IMSM_101509 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 69 | IME_100755 | Human Blood / IMSM_101510 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 70 | IME_100756 | Human Blood / IMSM_101511 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 71 | IME_100757 | Human Blood / IMSM_101512 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 72 | IME_100758 | Human Blood / IMSM_101513 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 73 | IME_100759 | Human Blood / IMSM_101514 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 74 | IME_100760 | Human Blood / IMSM_101515 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 75 | IME_100761 | Human Blood / IMSM_101516 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 76 | IME_100762 | Human Blood / IMSM_101517 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| 77 | IME_100763 | Human Blood / IMSM_101518 | 3-(Trimethylsilyl)propionic acid-d₄ sodium salt (TSP) | Bruker Avance III HD 800 Mhz|IMDA_NMR_100006 | Solution-State NMR | 1D 1H | 800 MHz | Triple-resonance CPTCI cryogenic cooled probehead equipped with z-gradient | 298K | D2O | 5 mm | Topspin |
| Sr.No | First name | Last name | Organization | Designation | |
|---|---|---|---|---|---|
| 1 | Dr. Neeraj | Sinha | neerajcbmr@gmail.com | Centre of Biomedical Research | co_principal_investigator |
| 2 | Dr. Dharmendra | Bhadauriaria | docdharm10@gmail.com | Sanjay Gandhi Postgraduate institute of medical science | principal_investigator |
| 3 | Dr.Bikash | Baishya | bikash2baishya@gmail.com | Centre of Biomedical Research | principal_investigator |
| 4 | Upasna | Gupta | upasnagupta941@gmail.com | Centre of Biomedical Research | research_scholar |
| 5 | Amrita | Sahu | sahuamrita456@gmail.com | Centre of Biomedical Research | research_scholar |
| Sr.No | ftprun ID | NMR Exp ID | NMR Data Files |
|---|---|---|---|
| 1 | IMR_101286 | IME_100687 | 190.zip |
| 2 | IMR_101287 | IME_100688 | 191.zip |
| 3 | IMR_101288 | IME_100689 | 192.zip |
| 4 | IMR_101289 | IME_100690 | 193.zip |
| 5 | IMR_101290 | IME_100691 | 194.zip |
| 6 | IMR_101291 | IME_100692 | 195.zip |
| 7 | IMR_101292 | IME_100693 | 196.zip |
| 8 | IMR_101293 | IME_100694 | 197.zip |
| 9 | IMR_101294 | IME_100695 | 198.zip |
| 10 | IMR_101295 | IME_100696 | 199.zip |
| 11 | IMR_101296 | IME_100697 | 200.zip |
| 12 | IMR_101297 | IME_100698 | 201.zip |
| 13 | IMR_101298 | IME_100699 | 202.zip |
| 14 | IMR_101299 | IME_100700 | 203.zip |
| 15 | IMR_101300 | IME_100701 | 204.zip |
| 16 | IMR_101301 | IME_100702 | 205.zip |
| 17 | IMR_101302 | IME_100703 | 206.zip |
| 18 | IMR_101303 | IME_100704 | 207.zip |
| 19 | IMR_101304 | IME_100705 | 208.zip |
| 20 | IMR_101305 | IME_100706 | 209.zip |
| 21 | IMR_101306 | IME_100707 | 210.zip |
| 22 | IMR_101307 | IME_100708 | 211.zip |
| 23 | IMR_101308 | IME_100709 | 212.zip |
| 24 | IMR_101309 | IME_100710 | 182.zip |
| 25 | IMR_101310 | IME_100711 | 183.zip |
| 26 | IMR_101311 | IME_100712 | 184.zip |
| 27 | IMR_101312 | IME_100713 | 185.zip |
| 28 | IMR_101313 | IME_100714 | 186.zip |
| 29 | IMR_101314 | IME_100715 | 187.zip |
| 30 | IMR_101315 | IME_100716 | 188.zip |
| 31 | IMR_101316 | IME_100717 | 189.zip |
| 32 | IMR_101317 | IME_100718 | 315.zip |
| 33 | IMR_101318 | IME_100719 | 317.zip |
| 34 | IMR_101319 | IME_100720 | 321.zip |
| 35 | IMR_101320 | IME_100721 | 323.zip |
| 36 | IMR_101321 | IME_100722 | 325.zip |
| 37 | IMR_101322 | IME_100723 | 358.zip |
| 38 | IMR_101323 | IME_100724 | 360.zip |
| 39 | IMR_101324 | IME_100725 | 362.zip |
| 40 | IMR_101325 | IME_100726 | 364.zip |
| 41 | IMR_101326 | IME_100727 | 366.zip |
| 42 | IMR_101327 | IME_100728 | 367.zip |
| 43 | IMR_101328 | IME_100729 | 398.zip |
| 44 | IMR_101329 | IME_100730 | 407.zip |
| 45 | IMR_101330 | IME_100731 | 408.zip |
| 46 | IMR_101331 | IME_100732 | 409.zip |
| 47 | IMR_101332 | IME_100733 | 410.zip |
| 48 | IMR_101333 | IME_100734 | 411.zip |
| 49 | IMR_101334 | IME_100735 | 412.zip |
| 50 | IMR_101335 | IME_100736 | 413.zip |
| 51 | IMR_101336 | IME_100737 | 414.zip |
| 52 | IMR_101337 | IME_100738 | 415.zip |
| 53 | IMR_101338 | IME_100739 | 416.zip |
| 54 | IMR_101339 | IME_100740 | 417.zip |
| 55 | IMR_101340 | IME_100741 | 418.zip |
| 56 | IMR_101341 | IME_100742 | 419.zip |
| 57 | IMR_101342 | IME_100743 | 1.zip |
| 58 | IMR_101343 | IME_100744 | 3.zip |
| 59 | IMR_101344 | IME_100745 | 5.zip |
| 60 | IMR_101345 | IME_100746 | 7.zip |
| 61 | IMR_101346 | IME_100747 | 9.zip |
| 62 | IMR_101347 | IME_100748 | 11.zip |
| 63 | IMR_101348 | IME_100749 | 15.zip |
| 64 | IMR_101349 | IME_100750 | 20.zip |
| 65 | IMR_101350 | IME_100751 | 22.zip |
| 66 | IMR_101351 | IME_100752 | 24.zip |
| 67 | IMR_101352 | IME_100753 | 26.zip |
| 68 | IMR_101353 | IME_100754 | 31.zip |
| 69 | IMR_101354 | IME_100755 | 33.zip |
| 70 | IMR_101355 | IME_100756 | 35.zip |
| 71 | IMR_101356 | IME_100757 | 36.zip |
| 72 | IMR_101357 | IME_100758 | 37.zip |
| 73 | IMR_101358 | IME_100759 | 38.zip |
| 74 | IMR_101359 | IME_100760 | 39.zip |
| 75 | IMR_101360 | IME_100761 | 40.zip |
| 76 | IMR_101361 | IME_100762 | 41.zip |
| 77 | IMR_101362 | IME_100763 | 42.zip |
Download Metabolite/Compound
| Sr.No | Structure | Details |
|---|---|---|
| 1 |
|
3-HydroxybutyrateCHEBI ID: 37054.0 PubChem ID: 3541112 Chemical Formula: C4H7O3- Smiles: CC(CC(=O)[O-])O InChI: InChI=1S/C4H8O3/c1-3(5)2-4(6)7/h3,5H,2H2,1H3,(H,6,7)/p-1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 2 |
|
2-HydroxyisovalerateCHEBI ID: 64669.0 PubChem ID: 99823 Chemical Formula: C5H9O3 Smiles: CC(C)C(O)C(=O)[O-] InChI: InChI=1S/C5H10O3/c1-3(2)4(6)5(7)8/h3-4,6H,1-2H3,(H,7,8)/p-1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 3 |
|
AcetateCHEBI ID: 30089.0 PubChem ID: 175 Chemical Formula: C2H3O2 Smiles: CC(=O)[O-] InChI: InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)/p-1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 4 |
|
AcetoneCHEBI ID: 15347.0 PubChem ID: 180 Chemical Formula: C3H6O Smiles: CC(C)=O InChI: InChI=1S/C3H6O/c1-3(2)4/h1-2H3 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 5 |
|
AlanineCHEBI ID: 16449.0 PubChem ID: 5950 Chemical Formula: C3H7NO2 Smiles: CC(N)C(=O)O InChI: InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 6 |
|
ArginineCHEBI ID: 16467.0 PubChem ID: 6322 Chemical Formula: C6H14N4O2 Smiles: N=C(N)NCCC[C@H](N)C(=O)O InChI: InChI=1S/C6H14N4O2/c7-4(5(11)12)2-1-3-10-6(8)9/h4H,1-3,7H2,(H,11,12)(H4,8,9,10)/t4-/m0/s1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 7 |
|
AspartateCHEBI ID: 29991.0 PubChem ID: 5960 Chemical Formula: C4H6NO4 Smiles: [NH3+][C@@H](CC(=O)[O-])C(=O)[O-] InChI: InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/p-1/t2-/m0/s1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 8 |
|
AsparagineCHEBI ID: 22653.0 PubChem ID: 6269 Chemical Formula: C4H8N2O3 Smiles: NC(=O)CC(N)C(=O)O InChI: InChI=1S/C4H8N2O3/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H2,6,7)(H,8,9) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 9 |
|
BetaineCHEBI ID: 17750.0 PubChem ID: 247 Chemical Formula: C5H11NO2 Smiles: C[N+](C)(C)CC(=O)[O-] InChI: InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 10 |
|
CitrateCHEBI ID: 16947.0 PubChem ID: 31348 Chemical Formula: C6H5O7-3 Smiles: C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O InChI: InChI=1S/C6H8O7/c7-3(8)1-6(13,5(11)12)2-4(9)10/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/p-3 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 11 |
|
CreatineCHEBI ID: 16919.0 PubChem ID: 586 Chemical Formula: C4H9N3O2 Smiles: CN(CC(=O)O)C(=N)N InChI: InChI=1S/C4H9N3O2/c1-7(4(5)6)2-3(8)9/h2H2,1H3,(H3,5,6)(H,8,9) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 12 |
|
CreatinineCHEBI ID: 16737.0 PubChem ID: 588 Chemical Formula: C4H7N3O Smiles: CN1CC(=O)NC1=N InChI: InChI=1S/C4H7N3O/c1-7-2-3(8)6-4(7)5/h2H2,1H3,(H2,5,6,8) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 13 |
|
CholineCHEBI ID: 15354.0 PubChem ID: 305 Chemical Formula: C5H14NO Smiles: C[N+](C)(C)CCO InChI: InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 14 |
|
DimethylamineCHEBI ID: 17170.0 PubChem ID: 674 Chemical Formula: C2H7N Smiles: [H]N(C)C InChI: InChI=1S/C2H7N/c1-3-2/h3H,1-2H3 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 15 |
|
DimethylSufloneCHEBI ID: 9349.0 PubChem ID: 6213 Chemical Formula: C2H6O2S Smiles: CS(C)(=O)=O InChI: InChI=1S/C2H6O2S/c1-5(2,3)4/h1-2H3 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 16 |
|
EthylmalonateCHEBI ID: 132938.0 PubChem ID: NA Chemical Formula: NA Smiles: NA InChI: NA Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 17 |
|
FormateCHEBI ID: 15740.0 PubChem ID: 283 Chemical Formula: CHO2 Smiles: [H]C(=O)[O-] InChI: InChI=1S/CH2O2/c2-1-3/h1H,(H,2,3)/p-1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 18 |
|
GlucoseCHEBI ID: 17234.0 PubChem ID: 5793 Chemical Formula: C6H12O6 Smiles: C([C@@H]1[C@H]([C@@H]([C@H](C(O1)O)O)O)O)O InChI: InChI=1S/C6H12O6/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-11H,1H2/t2-,3-,4+,5-,6?/m1/s1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 19 |
|
GlutamateCHEBI ID: 29988.0 PubChem ID: 14598502 Chemical Formula: C5H7NO4 Smiles: N[C@@H](CCC(=O)[O-])C(=O)[O-] InChI: InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/p-2/t3-/m0/s1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 20 |
|
GlutamineCHEBI ID: 28300.0 PubChem ID: 5961 Chemical Formula: C5H10N2O3 Smiles: NC(=O)CCC(N)C(=O)O InChI: InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 21 |
|
GlycineCHEBI ID: 15428.0 PubChem ID: 750 Chemical Formula: C2H5NO2 Smiles: NCC(=O)O InChI: InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 22 |
|
HistidineCHEBI ID: 27570.0 PubChem ID: 6274 Chemical Formula: C6H9N3O2 Smiles: NC(Cc1cncn1)C(=O)O InChI: InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 23 |
|
HippurateCHEBI ID: NA PubChem ID: NA Chemical Formula: NA Smiles: NA InChI: NA Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 24 |
|
HypoxanthineCHEBI ID: 17368.0 PubChem ID: 135398638 Chemical Formula: C5H4N4O Smiles: O=c1ncnc2ncnc12 InChI: InChI=1S/C5H4N4O/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 25 |
|
IsobutyrateCHEBI ID: 48944.0 PubChem ID: 165337 Chemical Formula: C4H7O2 Smiles: CC(C)C(=O)[O-] InChI: InChI=1S/C4H8O2/c1-3(2)4(5)6/h3H,1-2H3,(H,5,6)/p-1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 26 |
|
IsoleucineCHEBI ID: 24898.0 PubChem ID: 6306 Chemical Formula: C6H13NO2 Smiles: CC[C@H](C)[C@@H](C(=O)O)N InChI: InChI=1S/C6H13NO2/c1-3-4(2)5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t4-,5-/m0/s1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 27 |
|
LactateCHEBI ID: 24996.0 PubChem ID: 91435 Chemical Formula: C3H5O3 Smiles: CC(O)C(=O)[O-] InChI: InChI=1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/p-1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 28 |
|
LeucineCHEBI ID: 25017.0 PubChem ID: 6106 Chemical Formula: C6H13NO2 Smiles: CC(C)CC(N)C(=O)O InChI: InChI=1S/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 29 |
|
LysineCHEBI ID: 25094.0 PubChem ID: 5962 Chemical Formula: C6H14N2O2 Smiles: NCCCCC(N)C(=O)O InChI: InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 30 |
|
MethionineCHEBI ID: 16811.0 PubChem ID: 6137 Chemical Formula: C5H11NO2S Smiles: CSCCC(N)C(=O)O InChI: InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 31 |
|
Myo-inositolCHEBI ID: 17268.0 PubChem ID: 516572213 Chemical Formula: C6H12O6 Smiles: O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O InChI: InChI=1S/C6H12O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-12H/t1-,2-,3-,4+,5-,6- Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 32 |
|
N, N-DimethylglycineCHEBI ID: 17724.0 PubChem ID: 673 Chemical Formula: C4H9NO2 Smiles: CN(C)CC(=O)O InChI: InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 33 |
|
ProlineCHEBI ID: 26271.0 PubChem ID: 145742 Chemical Formula: C5H9NO2 Smiles: O=C(O)C1CCCN1 InChI: InChI=1S/C5H9NO2/c7-5(8)4-2-1-3-6-4/h4,6H,1-3H2,(H,7,8) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 34 |
|
PyruvateCHEBI ID: 15361.0 PubChem ID: 107735 Chemical Formula: C3H3O3 Smiles: CC(=O)C(=O)[O-] InChI: InChI=1S/C3H4O3/c1-2(4)3(5)6/h1H3,(H,5,6)/p-1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 35 |
|
PhenylalanineCHEBI ID: 28044.0 PubChem ID: 6140 Chemical Formula: C9H11NO2 Smiles: NC(Cc1ccccc1)C(=O)O InChI: InChI=1S/C9H11NO2/c10-8(9(11)12)6-7-4-2-1-3-5-7/h1-5,8H,6,10H2,(H,11,12) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 36 |
|
SuccinateCHEBI ID: 26806.0 PubChem ID: 160419 Chemical Formula: C4H4O4-2 Smiles: C(CC(=O)[O-])C(=O)[O-] InChI: InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)/p-2 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 37 |
|
TrimethylamineCHEBI ID: 18139.0 PubChem ID: 1146 Chemical Formula: C3H9N Smiles: CN(C)C InChI: InChI=1S/C3H9N/c1-4(2)3/h1-3H3 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 38 |
|
Trimethylamine N- oxideCHEBI ID: 15724.0 PubChem ID: 1145 Chemical Formula: C3H9NO Smiles: C[N+](C)(C)[O-] InChI: InChI=1S/C3H9NO/c1-4(2,3)5/h1-3H3 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 39 |
|
ThreonineCHEBI ID: 26986.0 PubChem ID: 6288 Chemical Formula: C4H9NO3 Smiles: C[C@H]([C@@H](C(=O)O)N)O InChI: InChI=1S/C4H9NO3/c1-2(6)3(5)4(7)8/h2-3,6H,5H2,1H3,(H,7,8)/t2-,3+/m1/s1 Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 40 |
|
TyrosineCHEBI ID: 18186.0 PubChem ID: 6057 Chemical Formula: C9H11NO3 Smiles: NC(Cc1ccc(O)cc1)C(=O)O InChI: InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 41 |
|
UreaCHEBI ID: 16199.0 PubChem ID: 1176 Chemical Formula: CH4N2O Smiles: NC(N)=O InChI: InChI=1S/CH4N2O/c2-1(3)4/h(H4,2,3,4) Mass to charge: NA Retention Time: NA Chemical Shift: NA |
| 42 |
|
ValineCHEBI ID: 27266.0 PubChem ID: 6268 Chemical Formula: C5H11NO2 Smiles: CC(C)C(N)C(=O)O InChI: InChI=1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8) Mass to charge: NA Retention Time: NA Chemical Shift: NA |